Financing - June 27, 2019
Nexstim receives funding from Wings for Life Foundation
The Helsinki University Hospital in Finland has received significant funding from the renowned Wings for Life Foundation to continue its research into spinal cord injury rehabilitation using Nexstim’s SmartFocus technology. Wings for Life specifically supports international research focused on finding new treatment methods for spinal cord injury patients whose rehabilitation is known to be highly […]
New Market - May 13, 2019
Nexstim enters depression therapy market in Sweden
Nexstim’s business partner PO Medica AB has sold two Navigated Brain Therapy (NBT) systems to two different hospitals Sweden. Both hospitals will be the first in Sweden to have the NBT systems and it will be their first time using navigated Transcranial Magnetic Stimulation (TMS) for the treatment of MDD. The systems will be used for the […]
Financing - January 23, 2018
Nexstim receives R&D loan from Business Finland
The medtech company announces that Business Finland has granted them an R&D loan amounting to approximately EUR 1 million for the development of a next-generation user interface (GUI) for the Navigated Brain Therapy (NBT) System indicated for the treatment of Major Depressive Disorder (MDD) and chronic neuropathic pain. To enable extensive therapeutic use of the […]
Clinical Trials Medtech - January 8, 2018
Nexstim enrols last patient in supplementary Phase III trial
The company has successfully completed enrolment in its supplementary Phase III clinical trial, known as E-FIT (ELECTRIC FIELD NAVIGATED 1HZ RTMS FOR POST-STROKE MOTOR RECOVERY TRIAL), evaluating the use of Nexstim’s NBT system in upper extremity motor rehabilitation following stroke. The supplemental trial is being conducted at five clinical centres in the US and has […]
In a new job - December 8, 2017
New VP and General Manager, North America at Nexstim
He will be effective in his new role from 1 January 2018. Steve Beller has experience in the US neuro-stimulation market where he was most recently Area Vice-President at Abbott Neuromodulation, managing a team of over 170 people in the Western half of the US. Prior to this, Mr. Beller held Senior Director and Regional […]
Financing - October 26, 2017
Nexstim raises EUR 1.75 million
Nexstim announces that it is raising new equity financing of the gross amount EUR 1.75 million via a directed issue of new shares to a London-based fund managed by City Financial Investment Company Limited. The Company’s Board of Directors resolved to issue up to 7,000,000 new shares at a subscription price of EUR 0.25 per […]
